Cardiff Oncology, Inc. · NASDAQ:CRDF
Cardiff Oncology, Inc. shareholders
As of Jun 30, 2026, 101 institutions reported holding Cardiff Oncology, Inc., 24.2% of its shares. Largest: Vanguard, Laurion Capital Management LP and Pfizer Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cardiff Oncology, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 3.4M | 4.4% | −361K | Aug 13, 2026 |
| Laurion Capital Management LP | 3.1M | 4.0% | +452K | Aug 13, 2026 |
| Pfizer Inc | 2.41M | 3.1% | no change | Aug 13, 2026 |
| Franklin Templeton | 1.21M | 1.5% | no change | Aug 13, 2026 |
| BlackRock | 973K | 1.3% | −3.01M | Aug 7, 2026 |
| Blair William & Co | 913K | 1.2% | −9,894 | Aug 11, 2026 |
| Geode Capital | 820K | 1.1% | −780K | Aug 12, 2026 |
| UBS | 639K | 0.82% | +238K | Aug 13, 2026 |
| Jane Street | 608K | 0.78% | +568K | Aug 14, 2026 |
| AQR Capital Management LLC | 346K | 0.45% | +280K | Aug 14, 2026 |